Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06913985

Trajectory Study: Predicting Cardiometabolic Health in Adolescents and Young Adults Based on Childhood Fitness, Sleep, and Diet

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Arkansas Children's Hospital Research Institute · Academic / Other
Sex
All
Age
13 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The Trajectory study aims to determine whether childhood aerobic fitness, sleep quality, and diet quality predict cardiometabolic health during puberty and early adulthood, independently of adiposity.

Detailed description

The Trajectory study is a longitudinal observational study. Participants will be recalled from two existing pediatric cohorts: the Arkansas Active Kids study (ClinicalTrials.gov ID: NCT03221673; IRB #206217) and the MI Energy study (ClinicalTrials.gov ID: NCT04427462; IRB #260376). Both were cross-sectional studies with comparable designs, recruiting children between ages 7 and 10 years, regardless of sex, BMI, or ethnicity. The Trajectory study serves as the follow-up component during adolescence or early adulthood (ages 13-21). It is anticipated that approximately 250 participants will complete the follow-up visit. During the follow-up visit at the Arkansas Children's Nutrition Center (ACNC), the following key measurements will be conducted: * Body Composition: Dual-Energy X-ray Absorptiometry (DXA) * Metabolic Profile: Fasting blood markers, including glucose, lipid profile, and insulin resistance * Continuous Glucose Monitoring: Interstitial sensor-based glucose * Vascular Function: Ultrasound (brachial artery flow-mediated dilation) * Liver Examination: Ultrasound (liver steatosis and stiffness) * Resting Metabolic Rate: Indirect calorimetry * Aerobic Capacity: Cardiopulmonary exercise test (spirometry) * Muscle Strength: Dynamometry * Physical Activity \& Sleep: Accelerometry * Dietary Intake: Food frequency questionary

Conditions

Timeline

Start date
2025-05-20
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2025-04-06
Last updated
2025-07-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06913985. Inclusion in this directory is not an endorsement.